No abstract available
MeSH terms
-
Aged
-
Angiogenesis Inhibitors / adverse effects
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bevacizumab
-
Chemotherapy, Adjuvant
-
Colonic Neoplasms / blood
-
Colonic Neoplasms / complications
-
Colonic Neoplasms / drug therapy*
-
Colonic Neoplasms / pathology
-
Hemophilia B / blood
-
Hemophilia B / complications*
-
Hemophilia B / drug therapy
-
Hemorrhage / blood
-
Hemorrhage / chemically induced
-
Hemostasis / drug effects
-
Humans
-
Liver Neoplasms / blood
-
Liver Neoplasms / complications
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / secondary
-
Male
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab